3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Carcinoma, Non-Small-Cell Lung
37
Lung Neoplasms
21
Brain Neoplasms
21
Prostatic Neoplasms
20
Pancreatic Neoplasms
20
Neoplasm Metastasis
20
Carcinoma, Hepatocellular
17
Melanoma
15
Breast Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
8
Carcinoma, Renal Cell
8
Neoplasms
7
Small Cell Lung Carcinoma
6
Liver Neoplasms
6
Glioblastoma
6
Sarcoma
5
Head and Neck Neoplasms
4
Salivary Gland Neoplasms
3
Recurrence
3
Kidney Neoplasms
3
Gliosarcoma
3
Glioma
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Adenocarcinoma of Lung
3
Uveal Melanoma
2
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Sarcoma, Ewing
2
Interventions
Carboplatin
23
Cisplatin
19
pembrolizumab
14
Paclitaxel
12
Gemcitabine
12
Pemetrexed
11
130-nm albumin-bound paclitaxel
9
Everolimus
8
Cetuximab
8
Fluorouracil
7
Axitinib
6
osimertinib
5
durvalumab
5
Sunitinib
5
Radiotherapy
5
Erlotinib Hydrochloride
5
Docetaxel
5
Cyclophosphamide
5
Albumin-Bound Paclitaxel
5
Sorafenib
4
Radiation
4
Nivolumab
4
Ipilimumab
4
vosaroxin
3
Radiotherapy, Intensity-Modulated
3
Octreotide
3
Irinotecan
3
Bevacizumab
3
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
3
pralsetinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma
×
Radiosurgery
×
Clear all
NCT04939246
2025-07-17
SMART ONE
Baptist Health South Florida
Phase NA
Completed
30 enrolled
20 charts